| Old Articles: <Older 26291-26300 Newer> |
|---|
 |
The Motley Fool
September 25, 2007
Anders Bylund |
The Movie Gallery Shooting Gallery After three straight extensions to its credit terms, Movie Gallery decides to close over 500 locations and sell off some inventory.   |
The Motley Fool
September 25, 2007
Brian Orelli |
No Drugs, No Rally Sonus Pharmaceuticals' lead drug fails in phase 3 trials, so the stock crashes. |
The Motley Fool
September 25, 2007
Brian Orelli |
Cold HIV Vaccine Gets Frozen Phase 2 clinical trials of Merck's HIV vaccine were frozen, leaving the door open for other drugmakers that have vaccines of their own in early trials. Investors, take note. |
The Motley Fool
September 25, 2007
Tom Taulli |
Ariba Gets Another Face-Lift The enterprise software company acquires privately-held Procuri in an effort to move closer to a subscription-based, on-demand business model. |
The Motley Fool
September 25, 2007
Tom Taulli |
Larry Ellison Doesn't Dig the Net According to its CEO, Oracle's strategy will not include a major shift to web-based business software anytime soon. |
The Motley Fool
September 25, 2007
Anders Bylund |
Marcus Hits the Mark: Fool by Numbers The hotel and movie maven reported first-quarter 2008 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool
September 25, 2007
Rich Duprey |
Foolish Forecast: Not Much to Build On at KB Home In advance of third-quarter reports for KB Home, analysts are expecting a loss; perhaps even a mega-loss. |
The Motley Fool
September 25, 2007
Rich Smith |
Foolish Forecast: Paychex Manages In advance of fiscal 2008 Q1 earnings reports, Paychex's CEO reminds investors that fiscal 2007 was the company's seventeenth consecutive year of record revenues and net income, a trend he expects to continue. |
The Motley Fool
September 25, 2007
Tom Taulli |
SYNNEX's Not-So-Simple Plan The IT distributor's third-quarter improvement prompts yawns from Wall Street, perhaps due to increased spending. Investors, take note. |
The Motley Fool
September 25, 2007
Rich Smith |
Foolish Forecast: Bed Bath & Beyond the Decline In advance of Bed, Bath & Beyond's earnings reports, analysts are looking for 10% sales growth at the retailer. |
| <Older 26291-26300 Newer> Return to current articles. |
